Skip to main content
. 2018 Jun 14;7(7):3453–3464. doi: 10.1002/cam4.1597

Table 4.

The associations between potential risk factors and oral Epstein‐Barr virus load levels among NPC cases and healthy controls

Variables NPC cases Healthy controls
EBV loads (copies/mL)a Adjusted OR (95% CI)b P EBV loads (copies/mL)a Adjusted OR (95% CI)b P
<33 978 , N(%) ≥33 978, N(%) <33 987, N(%) ≥33 987, N(%)
Age
<40 182 (29.50) 83 (23.65) 1.00 (reference) / 288 (34.78) 223 (26.93) 1.00 (reference) /
40‐49 206 (33.39) 112 (31.91) 1.36 (0.94‐1.96) .101 271 (32.73) 229 (27.66) 1.06 (0.82‐1.38) .647
50‐59 164 (26.58) 105 (29.91) 1.73 (1.18‐2.55) .005 173 (20.89) 247 (29.83) 1.75 (1.32‐2.34) <.001
≥60 65 (10.53) 51 (14.53) 2.18 (1.34‐3.56) .002 96 (11.59) 129 (15.58) 1.65 (1.17‐2.34) .005
P trend c <.001 <.001
Sex
Female 172 (27.88) 82 (23.36) 1.00 (reference) / 308 (37.20) 183 (22.10) 1.00 (reference) /
Male 445 (72.12) 269 (76.64) 1.34 (0.90‐2.00) .155 520 (62.80) 645 (77.90) 1.65 (1.25‐2.18) <.001
Education years
≤6 166 (26.99) 71 (20.29) 1.00 (reference) / 118 (14.29) 107 (12.97) 1.00 (reference) /
7‐12 374 (60.81) 230 (65.71) 1.55 (1.09‐2.21) .015 444 (53.75) 447 (54.18) 1.29 (0.94‐1.78) .111
>13 75 (12.20) 49 (14.00) 1.65 (1.00‐2.72) .049 264 (31.96) 271 (32.85) 1.59 (1.11‐2.26) .011
P trend c .027 .010
VCA‐IgA
≤1:40 64 (10.37) 73 (20.80) 1.00 (reference) / 822 (99.28) 821 (99.15) 1.00 (reference) /
1:40‐1:160 199 (32.25) 120 (34.19) 0.51 (0.34‐0.78) .002 5 (0.60) 5 (0.60) 0.95 (0.26‐3.51) .934
1:160‐1:640 288 (46.68) 134 (38.18) 0.38 (0.25‐0.57) <.001 1 (0.12) 2 (0.24) 1.47 (0.13‐17.09) .759
>1:640 66 (10.70) 24 (6.84) 0.28 (0.15‐0.51) <.001 0 (0.00) 0 (0.00) .862
P trend c <.001
EA‐IgA
≤1:10 224 (36.30) 166 (47.29) 1.00 (reference) / 828 (100.00) 828 (100.00) 1.00 (reference) /
1:10‐1:40 218 (35.33) 114 (32.48) 0.63 (0.46‐0.87) .005 0 (0.00) 0 (0.00) / /
1:80‐1:160 149 (24.15) 68 (19.37) 0.52 (0.36‐0.75) <.001 0 (0.00) 0 (0.00) / /
>1:160 26 (4.21) 3 (0.85) 0.14 (0.04‐0.49) .002 0 (0.00) 0 (0.00) / /
P trend c <.001 /
Overall stage
I 19 (3.34) 12 (3.55) 1.00 (reference) /
II 93 (16.34) 56 (16.57) 1.10 (0.48‐2.49) .824
III 304 (53.43) 168 (49.70) 0.98 (0.46‐2.13) .968
IV 153 (26.89) 102 (30.18) 1.11 (0.50‐2.46) .800
P trend c .840
T stage
T1 39 (6.63) 15 (4.36) 1.00 (reference) /
T2 163 (27.72) 77 (22.38) 1.30 (0.66‐2.53) .446
T3 276 (46.94) 158 (45.93) 1.58 (0.83‐3.00) .165
T4 110 (18.71) 94 (27.33) 2.32 (1.17‐4.57) .015
P trend c .002
N stage
N0 118 (20.03) 108 (31.40) 1.00 (reference) /
N1 224 (38.03) 146 (42.44) 0.74 (0.52‐1.04) .085
N2 192 (32.60) 73 (21.22) 0.40 (0.27‐0.59) <.001
N3 55 (9.34) 17 (4.94) 0.32 (0.17‐0.60) <.001
P trend c <.001
M
M0 575 (97.79) 333 (97.65) 1.00 (reference) /
M1 13 (2.21) 8 (2.35) 0.80 (0.29‐2.16) .653
a

Oral EBV loads were assigned into 2 groups based on the median of that in healthy controls (33 978 copies/mL).

b

Multivariable logistic regressions were used by adjusting age (continuous variables), sex (males and females), education years (≤6, 7‐12, >13), cigarette smoking pack‐years (nonsmoker, <20, ≥20), alcohol drinking (non‐drinker, ≤1 drink per day, >1 drink per day), consumption of preserved vegetable (less than monthly, monthly, weekly, or more), and consumption of salted‐fish (less than monthly, monthly, weekly, or more).

c

Linear trends tests were performed by treating ordered categorical variables as continuous variables.